Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arbutus Biopharma Corp ABUS

Healthcare Biotechnology
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is leveraging its virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can potentially be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV) infection. Its HBV product pipeline includes Imdusiran and AB-101. Imdusiran... see more

Recent & Breaking News (NDAQ:ABUS)

Tekmira Announces Pricing of Underwritten Public Offering of Common Shares

GlobeNewswire March 20, 2015

Tekmira Announces Proposed Public Offering of Common Shares

GlobeNewswire March 18, 2015

Tekmira Strengthens Senior Leadership Team With Key Executive Appointments in Corporate Affairs, Chemistry and Biology

GlobeNewswire March 18, 2015

Tekmira Provides Corporate Update and Announces Year-End 2014 Results

GlobeNewswire March 12, 2015

TKM-Ebola-Guinea Enters Phase II Clinical Study in Sierra Leone

GlobeNewswire March 11, 2015

Tekmira to Present at Barclays Global Healthcare Conference

GlobeNewswire March 6, 2015

Tekmira Conference Call and Webcast Advisory: Corporate Update and Full Year 2014 Financial Results

GlobeNewswire March 5, 2015

Tekmira Announces Completion of the Merger With OnCore Creating a Leading Hepatitis B Solutions Company

GlobeNewswire March 4, 2015

99.5% of Tekmira Shareholders Vote in Favor of Merger

GlobeNewswire March 3, 2015

Tekmira Announces Update to Its Proxy Circular on the Proposed Business Combination With OnCore Biopharma Inc.

GlobeNewswire February 25, 2015

S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices

Canada NewsWire February 17, 2015

Tekmira to Present at RBC Capital Markets' Healthcare Conference

GlobeNewswire February 12, 2015

Tekmira Announces Filing of Definitive Proxy Statement and Voluntary Delisting From the TSX

GlobeNewswire February 4, 2015

Tekmira Initiates Phase I Clinical Trial of TKM-HBV

GlobeNewswire January 21, 2015

Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company

GlobeNewswire January 11, 2015

Tekmira Provides Update on TKM-PLK1 Phase I/II Clinical Study in Patients With Advanced Gastrointestinal Neuroendocrine Tumors and Adrenocortical Carcinoma

GlobeNewswire December 31, 2014

Cantech Letter Announces Finalists for 2014 Cantech Letter Awards

Marketwired December 22, 2014

Tekmira Establishes Manufacturing and Clinical Trial Agreement to Provide TKM-Ebola-Guinea for Clinical Studies in West Africa

GlobeNewswire December 22, 2014

Tekmira Receives Clearance to Conduct a Phase I Clinical Study With TKM-HBV

GlobeNewswire December 22, 2014

Tekmira Pharmaceuticals Announces Leadership Changes

GlobeNewswire December 19, 2014